<?xml version="1.0" encoding="utf-8" standalone="yes"?>
<ReleaseSet Dated="2016-07-04" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" Type="full" xsi:noNamespaceSchemaLocation="http://ftp.ncbi.nlm.nih.gov/pub/clinvar/xsd_public/clinvar_public_1.35.xsd">

<ClinVarSet ID="36487111"><RecordStatus>current</RecordStatus><Title>NM_207352.3(CYP4V2):c.802-8_810del17insGC AND Bietti crystalline corneoretinal dystrophy</Title><ReferenceClinVarAssertion DateCreated="2013-01-08" DateLastUpdated="2018-12-28" ID="93199"><ClinVarAccession Acc="RCV000032548" Version="8" Type="RCV" DateUpdated="2018-12-29" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2017-02-06"><ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus><Description>Pathogenic</Description></ClinicalSignificance><Assertion Type="variation to disease" /><AttributeSet><Attribute Type="ModeOfInheritance" integerValue="263">Autosomal recessive inheritance</Attribute><XRef ID="73690472" DB="Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine" /></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData ID="35385517"><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><ObservedIn><Sample><Origin>not provided</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>not provided</AffectedStatus><NumberTested>1</NumberTested></Sample><Method><MethodType>literature only</MethodType></Method><Method><Purpose>assert pathogenicity</Purpose><MethodType>curation</MethodType></Method><ObservedData ID="35385518"><Attribute Type="Description">not provided</Attribute></ObservedData><ObservedData ID="35385518"><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>not provided</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><Method><MethodType>literature only</MethodType></Method><ObservedData ID="35385905"><Attribute integerValue="1" Type="VariantAlleles" /></ObservedData><ObservedData ID="35385905"><Attribute Type="Description">In 7 Japanese patients with Bietti crystalline corneoretinal dystrophy (BCD; 210370), Lin et al. (2005) identified homozygosity for an insertion/deletion mutation (c.802-8_810del17insGC) at intron 6 of the CYP4V2 gene that resulted in the skipping of exon 7. All 7 patients also shared homozygosity for 6 closely linked intragenic polymorphic markers, consistent with a founder effect; however, the authors noted that the founder was probably a very distant ancestor because the region of the conserved linked markers was small (6.7-17.1 kb). In a Chinese BCD patient, Lin et al. (2005) identified compound heterozygosity for this mutation and a c.992A-C transversion in the CYP4V2 gene, resulting in a his-331-to-pro (H331P; 608614.0007) substitution.</Attribute><Citation Type="general"><ID Source="PubMed">15937078</ID></Citation></ObservedData><ObservedData ID="35385905"><Attribute Type="Description">Li et al. (2004) had previously reported the indel mutation as a 15-bp deletion, which they found in homozygosity in 6 Japanese and 2 Chinese families with BCD as well as in 1 Japanese and 2 Chinese sporadic BCD patients. In addition, they identified the indel mutation in compound heterozygous state with the IVS8-2A-G mutation (608614.0005) in a Chinese patient with sporadic BCD and with the H331P mutation in affected individuals from a Chinese family. Screening for these 3 mutations in 50 controls, including 12 of Chinese, 16 of Japanese, and 22 of European origin, detected only 1 heterozygous instance of the H331P mutation in 1 Chinese control sample.</Attribute><Citation Type="general"><ID Source="PubMed">15042513</ID></Citation></ObservedData><ObservedData ID="35385905"><Attribute Type="Description">In 4 Chinese sisters with congenital cataract, high myopia, thin corneas, and a diagnosis of retinitis pigmentosa, Wang et al. (2012) identified compound heterozygosity for the c.802-8_810del17insGC mutation and the IVS8-2A-G mutation in the CYP4V2 gene. The mutations segregated fully with disease in 22 examined members of this 4-generation family.</Attribute><Citation Type="general"><ID Source="PubMed">22693542</ID></Citation></ObservedData><ObservedData ID="35385905"><Attribute Type="Description">In the proband from a Chinese family diagnosed with autosomal recessive RP, Fu et al. (2013) identified compound heterozygosity for the CYP4V2 c.802-8_810del17insGC (c.802-8_810del17insGC, NM_207352.3) and IVS8-2A-G mutations. Both mutations were also present in an affected sib, but mutation status was unknown for their unaffected deceased parents. Clinical reevaluation was not possible in this family, but reexamination of affected individuals in another Chinese RP family with mutations in CYP4V2 resulted in a rediagnosis of their phenotype as BCD (see 608614.0009).</Attribute><Citation Type="general"><ID Source="PubMed">23661369</ID></Citation></ObservedData><ObservedData ID="35385905"><Attribute integerValue="1" Type="NumFamiliesWithVariant" /></ObservedData></ObservedIn><MeasureSet Type="Variant" ID="39271"><Measure Type="Indel" ID="47877"><Name><ElementValue Type="Preferred">NM_207352.3(CYP4V2):c.802-8_810del17insGC</ElementValue></Name><AttributeSet><Attribute Change="c.802-8_810delinsGC" Accession="NM_207352" Version="3" Type="HGVS, coding">NM_207352.3:c.802-8_810delinsGC</Attribute></AttributeSet><AttributeSet><Attribute Change="c.802-8_810delTCATACAGGTCATCGCTinsGC" Accession="NM_207352" Version="3" Type="HGVS, coding">NM_207352.3:c.802-8_810delTCATACAGGTCATCGCTinsGC</Attribute><XRef ID="639241" DB="Illumina Clinical Services Laboratory,Illumina" /></AttributeSet><AttributeSet><Attribute Change="c.802-8_810del17insGC" Accession="NM_207352" Version="3" Type="HGVS, coding, RefSeq">NM_207352.3:c.802-8_810del17insGC</Attribute><XRef Type="Allelic variant" ID="608614.0006" DB="OMIM" /></AttributeSet><AttributeSet><Attribute Change="g.14630_14646delinsGC" Accession="NG_007965" Version="1" Type="HGVS, genomic">NG_007965.1:g.14630_14646delinsGC</Attribute></AttributeSet><AttributeSet><Attribute Change="g.14630_14646del17insGC" Accession="NG_007965" Version="1" Type="HGVS, genomic, RefSeqGene">NG_007965.1:g.14630_14646del17insGC</Attribute></AttributeSet><AttributeSet><Attribute Change="g.186201149_186201165del17insGC" Accession="NC_000004" Version="12" Type="HGVS, genomic, top level" integerValue="38">NC_000004.12:g.186201149_186201165del17insGC</Attribute></AttributeSet><AttributeSet><Attribute Change="g.187122303_187122319delinsGC" Accession="NC_000004" Version="11" Type="HGVS, genomic, top level, other" integerValue="37">NC_000004.11:g.187122303_187122319delinsGC</Attribute></AttributeSet><AttributeSet><Attribute Change="g.187122303_187122319del17insGC" Accession="NC_000004" Version="11" Type="HGVS, genomic, top level, previous" integerValue="37">NC_000004.11:g.187122303_187122319del17insGC</Attribute></AttributeSet><AttributeSet><Attribute Type="HGVS, protein">p.?</Attribute></AttributeSet><AttributeSet><Attribute Type="Location">NM_207352.3:intron 6</Attribute></AttributeSet><AttributeSet><Attribute Type="MolecularConsequence">intron variant</Attribute><XRef ID="SO:0001627" DB="Sequence Ontology" /><XRef ID="NM_207352.3:c.802-8_810del17insGC" DB="RefSeq" /></AttributeSet><AttributeSet><Attribute Type="nucleotide change">IVS6-8 del/insGC</Attribute></AttributeSet><CytogeneticLocation>4q35.2</CytogeneticLocation><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="186201149" stop="186201165" display_start="186201149" display_stop="186201165" alternateAllele="GC" positionVCF="186201149" referenceAlleleVCF="TCATACAGGTCATCGCT" alternateAlleleVCF="GC" /><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="187122303" stop="187122319" display_start="187122303" display_stop="187122319" alternateAllele="GC" positionVCF="187122303" referenceAlleleVCF="TCATACAGGTCATCGCT" alternateAlleleVCF="GC" /><MeasureRelationship Type="within single gene"><Name><ElementValue Type="Preferred">cytochrome P450 family 4 subfamily V member 2</ElementValue></Name><Symbol><ElementValue Type="Preferred">CYP4V2</ElementValue></Symbol><SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="4" Accession="NC_000004.12" start="186191520" stop="186213463" display_start="186191520" display_stop="186213463" Strand="+" /><SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="4" Accession="NC_000004.11" start="187112673" stop="187134616" display_start="187112673" display_stop="187134616" variantLength="21944" Strand="+" /><XRef ID="285440" DB="Gene" /><XRef Type="MIM" ID="608614" DB="OMIM" /><XRef ID="HGNC:23198" DB="HGNC" /></MeasureRelationship><Citation Type="general"><ID Source="PubMed">15860296</ID></Citation><XRef Type="Allelic variant" ID="608614.0006" DB="OMIM" /><XRef Type="rs" ID="207482233" DB="dbSNP" /></Measure><Name><ElementValue Type="Preferred">NM_207352.3(CYP4V2):c.802-8_810del17insGC</ElementValue></Name><XRef ID="CA343740" DB="ClinGen" /></MeasureSet><TraitSet Type="Disease" ID="559"><Trait ID="4671" Type="Disease"><Name><ElementValue Type="Preferred">Bietti crystalline corneoretinal dystrophy</ElementValue><XRef ID="Bietti+Crystalline+Corneoretinal+Dystrophy/825" DB="Genetic Alliance" /><XRef ID="10050" DB="Office of Rare Diseases" /></Name><Name><ElementValue Type="Alternate">Bietti Crystalline Dystrophy</ElementValue><XRef ID="NBK91457" DB="GeneReviews" /></Name><Symbol><ElementValue Type="Preferred">BCD</ElementValue><XRef Type="MIM" ID="210370" DB="OMIM" /><XRef ID="10050" DB="Office of Rare Diseases" /></Symbol><AttributeSet><Attribute Type="public definition">Bietti crystalline dystrophy (BCD) is a chorioretinal degeneration characterized by the presence of yellow-white crystals and/or complex lipid deposits in the retina. Progressive atrophy and degeneration of the retinal pigment epithelium (RPE) / choroid lead to symptoms similar to those of other forms of retinal degeneration that fall under the category of retinitis pigmentosa and allied disorders, namely: reduced visual acuity, poor night vision, abnormal retinal electrophysiology, visual field loss, and often impaired color vision. Marked asymmetry between eyes is common. Onset is typically during the second to third decade of life, but ranges from the early teenage years to beyond the third decade. With time, loss of peripheral visual field, central acuity, or both result in legal blindness in most, if not all, affected individuals.</Attribute><XRef ID="NBK91457" DB="GeneReviews" /></AttributeSet><Citation Type="review" Abbrev="GeneReviews"><ID Source="PubMed">22497028</ID><ID Source="BookShelf">NBK91457</ID></Citation><XRef ID="C1859486" DB="MedGen" /><XRef Type="MIM" ID="210370" DB="OMIM" /></Trait></TraitSet></ReferenceClinVarAssertion><ClinVarAssertion ID="92690"><ClinVarSubmissionID localKey="IVS6-8 del/insGC_NBK91457" submitter="GeneReviews" submitterDate="2013-03-26" title="IVS6-8 del/insGC and Bietti Crystalline Dystrophy" /><ClinVarAccession Acc="SCV000056215" Version="2" Type="SCV" OrgID="500062" OrganizationCategory="resource" OrgType="primary" DateUpdated="2018-11-26" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2012-04-12"><ReviewStatus>no assertion criteria provided</ReviewStatus><Description>pathologic</Description><Comment Type="ConvertedByNCBI">Converted during submission to Pathogenic.</Comment></ClinicalSignificance><Assertion Type="variation to disease" /><ExternalID DB="GeneReviews" ID="NBK91457" /><ObservedIn><Sample><Origin>not provided</Origin><Species>human</Species><AffectedStatus>not provided</AffectedStatus></Sample><Method><Purpose>Assert pathogenicity</Purpose><MethodType>curation</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="nucleotide change">IVS6-8 del/insGC</Attribute></AttributeSet></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">Bietti Crystalline Dystrophy</ElementValue></Name><XRef DB="GeneReviews" ID="NBK91457" /><XRef DB="OMIM" ID="210370" Type="MIM" /></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="310094" SubmissionName="targeted_exome_RP"><ClinVarSubmissionID localKey="NM_207352.3:c.802-8_810del17insGC|KYOTOUNIVOPHTHALMOL" submitter="Department of Ophthalmology and Visual Sciences Kyoto University" submitterDate="2014-07-29" /><ClinVarAccession Acc="SCV000172674" Version="1" Type="SCV" OrgID="505202" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2018-04-09" /><RecordStatus>current</RecordStatus><ClinicalSignificance><ReviewStatus>no assertion criteria provided</ReviewStatus><Description>pathogenic</Description><Comment>Converted during submission to Pathogenic.</Comment></ClinicalSignificance><Assertion Type="variation to disease" /><ObservedIn><Sample><Origin>not provided</Origin><Species>human</Species><AffectedStatus>not provided</AffectedStatus><NumberTested>1</NumberTested></Sample><Method><MethodType>not provided</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_207352.3:c.802-8_810del17insGC</Attribute></AttributeSet></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">Bietti crystalline corneoretinal dystrophy</ElementValue></Name><XRef DB="OMIM" ID="210370" Type="MIM" /></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="457710"><ClinVarSubmissionID localKey="608614.0006_BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY" submitter="OMIM" submitterDate="2015-09-26" title="CYP4V2, IVS6AS, 17-BP DEL/2-BP INS_BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY" /><ClinVarAccession Acc="SCV000246149" Version="1" Type="SCV" OrgID="3" OrganizationCategory="resource" OrgType="primary" DateUpdated="2018-04-09" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2013-06-14"><ReviewStatus>no assertion criteria provided</ReviewStatus><Description>Pathogenic</Description></ClinicalSignificance><Assertion Type="variation to disease" /><ExternalID DB="OMIM" ID="608614.0006" Type="Allelic variant" /><ObservedIn><Sample><Origin>germline</Origin><Species>human</Species><AffectedStatus>not provided</AffectedStatus></Sample><Method><MethodType>literature only</MethodType></Method><ObservedData><Attribute Type="Description">In 7 Japanese patients with Bietti crystalline corneoretinal dystrophy (BCD; 210370), Lin et al. (2005) identified homozygosity for an insertion/deletion mutation (c.802-8_810del17insGC) at intron 6 of the CYP4V2 gene that resulted in the skipping of exon 7. All 7 patients also shared homozygosity for 6 closely linked intragenic polymorphic markers, consistent with a founder effect; however, the authors noted that the founder was probably a very distant ancestor because the region of the conserved linked markers was small (6.7-17.1 kb). In a Chinese BCD patient, Lin et al. (2005) identified compound heterozygosity for this mutation and a c.992A-C transversion in the CYP4V2 gene, resulting in a his-331-to-pro (H331P; 608614.0007) substitution.</Attribute><Citation><ID Source="PubMed">15937078</ID></Citation><XRef DB="OMIM" ID="210370" Type="MIM" /></ObservedData><ObservedData><Attribute Type="Description">Li et al. (2004) had previously reported the indel mutation as a 15-bp deletion, which they found in homozygosity in 6 Japanese and 2 Chinese families with BCD as well as in 1 Japanese and 2 Chinese sporadic BCD patients. In addition, they identified the indel mutation in compound heterozygous state with the IVS8-2A-G mutation (608614.0005) in a Chinese patient with sporadic BCD and with the H331P mutation in affected individuals from a Chinese family. Screening for these 3 mutations in 50 controls, including 12 of Chinese, 16 of Japanese, and 22 of European origin, detected only 1 heterozygous instance of the H331P mutation in 1 Chinese control sample.</Attribute><Citation><ID Source="PubMed">15042513</ID></Citation></ObservedData><ObservedData><Attribute Type="Description">In 4 Chinese sisters with congenital cataract, high myopia, thin corneas, and a diagnosis of retinitis pigmentosa, Wang et al. (2012) identified compound heterozygosity for the c.802-8_810del17insGC mutation and the IVS8-2A-G mutation in the CYP4V2 gene. The mutations segregated fully with disease in 22 examined members of this 4-generation family.</Attribute><Citation><ID Source="PubMed">22693542</ID></Citation></ObservedData><ObservedData><Attribute Type="Description">In the proband from a Chinese family diagnosed with autosomal recessive RP, Fu et al. (2013) identified compound heterozygosity for the CYP4V2 c.802-8_810del17insGC (c.802-8_810del17insGC, NM_207352.3) and IVS8-2A-G mutations. Both mutations were also present in an affected sib, but mutation status was unknown for their unaffected deceased parents. Clinical reevaluation was not possible in this family, but reexamination of affected individuals in another Chinese RP family with mutations in CYP4V2 resulted in a rediagnosis of their phenotype as BCD (see 608614.0009).</Attribute><Citation><ID Source="PubMed">23661369</ID></Citation></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><Name><ElementValue Type="Preferred">CYP4V2, IVS6AS, 17-BP DEL/2-BP INS</ElementValue></Name><AttributeSet><Attribute Type="NonHGVS">IVS6AS, 17-BP DEL/2-BP INS</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">CYP4V2</ElementValue></Symbol></MeasureRelationship><XRef DB="OMIM" ID="608614.0006" Type="Allelic variant" /></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">BIETTI CRYSTALLINE CORNEORETINAL DYSTROPHY</ElementValue></Name></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="762364" SubmissionName="ICSL_2016Q4"><ClinVarSubmissionID localKey="639241|Bietti Crystalline Dystrophy" submittedAssembly="GRCh37" submitter="Illumina Clinical Services Laboratory,Illumina" submitterDate="2016-10-18" /><ClinVarAccession Acc="SCV000448843" Version="2" Type="SCV" OrgID="504895" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2018-05-03" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2016-06-14"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Pathogenic</Description><Citation><ID Source="PubMed">17962476</ID></Citation><Citation><ID Source="PubMed">15860296</ID></Citation><Citation><ID Source="PubMed">15042513</ID></Citation><Citation><ID Source="PubMed">26085992</ID></Citation><Citation><ID Source="PubMed">25593508</ID></Citation><Citation><ID Source="PubMed">21565171</ID></Citation><Citation><ID Source="PubMed">24739949</ID></Citation><Citation><ID Source="PubMed">26865810</ID></Citation><Citation><ID Source="PubMed">25629076</ID></Citation><Citation><ID Source="PubMed">22693542</ID></Citation><Comment>The c.802-8_810delTCATACAGGTCATCGCTinsGC variant, also described in the literature as c.802-8_810delinsG, occurs in a canonical splice site (acceptor) and is therefore predicted to disrupt or distort the normal gene product. The c.802-8_810delTCATACAGGTCATCGCTinsGC variant is the most common variant associated with Bietti crystalline dystrophy in the Japanese and Chinese populations, accounting for up to 83% of disease alleles (Park et al. 2016). The variant has been reported in at least nine studies in which it is found in at least 130 patients including 64 in a homozygous state, 65 in a compound heterozygous state and one individual in a heterozygous state in whom a second allele has not been detected (Li et al. 2004; Wada et al. 2006; Lai et al. 2007; Xiao et al. 2011; Yin et al. 2014; Meng et al. 2014; Tian et al. 2015; Park et al. 2016; Astuti et al. 2016). The variant was absent from 146 controls but is reported at a frequency of 0.00496 in the East Asian population of the 1000 Genomes Project. Due to the potential impact of splice acceptor variants and the supporting evidence from the literature, the c.802-8_810delTCATACAGGTCATCGCTinsGC variant is classified as pathogenic for Bietti crystalline dystrophy.</Comment></ClinicalSignificance><Assertion Type="variation to disease" /><ExternalID DB="Illumina Clinical Services Laboratory" ID="639241" /><AttributeSet><Attribute Type="AssertionMethod">ICSL Variant Classification 20161018</Attribute><Citation Type="general"><URL>https://submit.ncbi.nlm.nih.gov/ft/byid/4jQgNGYk/ICSL_Variant_Classification_20161018.pdf</URL><CitationText>ICSL_Variant_Classification_20161018.pdf</CitationText></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>unknown</AffectedStatus></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="Description">not provided</Attribute></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><AttributeSet><Attribute Type="HGVS">NM_207352.3:c.802-8_810delTCATACAGGTCATCGCTinsGC</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">CYP4V2</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><Name><ElementValue Type="Preferred">Bietti Crystalline Dystrophy</ElementValue></Name></Trait></TraitSet></ClinVarAssertion><ClinVarAssertion ID="1412652" SubmissionName="SUB3719835"><ClinVarSubmissionID localKey="73690472|Orphanet:ORPHA41751" submittedAssembly="GRCh37" submitter="Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine" submitterDate="2018-02-23" /><ClinVarAccession Acc="SCV000731492" Version="1" Type="SCV" OrgID="21766" OrganizationCategory="laboratory" OrgType="primary" DateUpdated="2018-10-13" /><RecordStatus>current</RecordStatus><ClinicalSignificance DateLastEvaluated="2017-02-06"><ReviewStatus>criteria provided, single submitter</ReviewStatus><Description>Pathogenic</Description><Citation><ID Source="PubMed">26085992</ID></Citation><Citation><ID Source="PubMed">17962476</ID></Citation><Citation><ID Source="PubMed">15860296</ID></Citation><Citation><ID Source="PubMed">23793346</ID></Citation><Citation><ID Source="PubMed">15937078</ID></Citation><Citation><ID Source="PubMed">23661369</ID></Citation><Citation><ID Source="PubMed">24739949</ID></Citation><Citation><ID Source="PubMed">21565171</ID></Citation><Citation><ID Source="PubMed">15042513</ID></Citation><Citation><ID Source="PubMed">25629076</ID></Citation><Citation><ID Source="PubMed">25593508</ID></Citation><Citation><ID Source="PubMed">26865810</ID></Citation><Citation><ID Source="PubMed">22693542</ID></Citation><Citation><ID Source="PubMed">19508456</ID></Citation><Comment Type="public">The c.802-8_810delinsGC (NM_207352.3 c.802-8_810delinsGC) variant in CYP4V2 has been reported in over 60 homozygous and compound heterozygous individuals with Bietti crystalline dystrophy and related disorders and is the most common variant associated with this disease in East Asian populations (Wada 2005, Lin 2005, Lai 2007, Yokoi 2010, Xiao 2011, Wang 2012, Chung 2013, Fu 2013, Yin 2014, Meng 2014, Tian 2015, Astuti 2015, and Park 2016). This variant has also been reported as pathogenic in ClinVar (Variation ID#39271). This variant has been identified in 0.2% (16/8520) of East Asian chromosomes by chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org). This variant alters the canonical splice site, and therefore is expected to impact splicing and lead to an absent or truncated protein. In summary, this variant meets criteria to be classified as pathogenic for Bietti crystalline dystrophy and related disorders in an autosomal recessive manner based upon its biallelic occurrence in patients with this disease and predicted functional impact.</Comment></ClinicalSignificance><Assertion Type="variation to disease" /><ExternalID DB="Laboratory for Molecular Medicine" ID="73690472" /><AttributeSet><Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute></AttributeSet><AttributeSet><Attribute Type="AssertionMethod">LMM Criteria</Attribute><Citation><ID Source="PubMed">24033266</ID></Citation></AttributeSet><ObservedIn><Sample><Origin>germline</Origin><Species TaxonomyId="9606">human</Species><AffectedStatus>not provided</AffectedStatus><FamilyData NumFamiliesWithVariant="1" /></Sample><Method><MethodType>clinical testing</MethodType></Method><ObservedData><Attribute Type="VariantAlleles" integerValue="1" /></ObservedData></ObservedIn><MeasureSet Type="Variant"><Measure Type="Variation"><Name><ElementValue Type="Alternate">NM_207352.3:c.802-8_810delinsGC</ElementValue></Name><Name><ElementValue Type="Alternate">p.?</ElementValue></Name><AttributeSet><Attribute Type="HGVS">NC_000004.11:g.187122303_187122319delinsGC</Attribute></AttributeSet><MeasureRelationship Type="variant in gene"><Symbol><ElementValue Type="Preferred">CYP4V2</ElementValue></Symbol></MeasureRelationship></Measure></MeasureSet><TraitSet Type="Disease"><Trait Type="Disease"><XRef DB="Orphanet" ID="ORPHA41751" /></Trait></TraitSet></ClinVarAssertion></ClinVarSet>

</ReleaseSet>